Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

14.70p
   
  • Change Today:
      0.95p
  • 52 Week High: 36.50
  • 52 Week Low: 9.55
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 3,575,038
  • Market Cap: £60.63m

Latest Deals

Traded Action Notifier PriceAmountValue
20-Jan-25 Buy Christopher Paul Hancock 19.10p 4,712 £899.99
16-Jan-25 Buy Richard John Rees 19.10p 4,712 £899.99
16-Jan-25 Buy Craig Jonathan Gulliford 19.10p 4,712 £899.99
13-Dec-24 Buy Kevin Crofton 17.02p 1,179,000 £200,606.85
24-Oct-24 Buy Richard John Rees 20.02p 76,740 £15,359.51

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
21-Oct-24 Buy Kevin Crofton 24.00p 2,916,666 £699,999.82
13-Dec-24 Buy Kevin Crofton 17.02p 1,179,000 £200,606.85
21-Oct-24 Buy Richard John Rees 24.00p 208,333 £49,999.92
24-Oct-24 Sell Richard John Rees 20.00p 174,740 £34,948.00
24-Oct-24 Buy Richard John Rees 20.02p 98,000 £19,614.70

Director Shareholdings

Notifier Holding Value*
Christopher Paul Hancock 4,838,793 £711,303
Kevin Crofton 4,745,666 £697,613
Richard John Rees 3,050,676 £448,449
Craig Jonathan Gulliford 1,666,907 £245,035
David Gerard Woods 440,255 £64,718
Charles Spicer 308,530 £45,354
Ivonne Cantu 125,000 £18,375

Major Shareholders

Notifier** Holding Value*
M&G Investments 47,478,836 £6,979,389
Canaccord Genuity Group Inc 36,014,293 £5,294,101
River Global Investors LLP 20,827,081 £3,061,581
Development Bank of Wales plc 14,376,727 £2,113,379
Finance Wales 12,776,727 £1,878,179
Baillie Gifford & Co 12,537,441 £1,843,004
Creo Medical Group EBT 10,000,000 £1,470,000
The Capital Group Companies, Inc. 8,816,807 £1,296,071
AXA Framlington Investment Managers 7,992,961 £1,174,965
Hargreave Hale Limited 6,753,632 £992,784
Tellworth Investments 5,772,778 £848,598
Hoya Corporation 4,799,880 £705,582
Jonathan Craton 3,400,294 £499,843
Cotterford Co Limited 3,335,398 £490,304
Mark Farmer 3,121,607 £458,876
RBC Trustees (CI) Ltd 2,974,727 £437,285
Angel Co Fund 2,967,120 £436,167

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 14.70p
Change Today 0.95p
% Change 6.91 %
52 Week High 36.50
52 Week Low 9.55
Volume 3,575,038
Shares Issued 412.47m
Market Cap £60.63m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
2.83% above the market average2.83% above the market average2.83% above the market average2.83% above the market average2.83% above the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average
Price Trend
70.16% below the market average70.16% below the market average70.16% below the market average70.16% below the market average70.16% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average
Income Not Available
Growth
47.38% below the market average47.38% below the market average47.38% below the market average47.38% below the market average47.38% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 28-May-2025

Time Volume / Share Price
11:13 67,114 @ 14.90p
11:12 1,942 @ 14.90p
11:03 8,000 @ 14.90p
11:02 3,564 @ 14.90p
10:57 30,000 @ 14.85p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page